| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5854270 | SANDOZ | Oral compositions containing ondansetron |
Nov, 2015
(8 years ago) | |
|
US5854270 (Pediatric) | SANDOZ | Oral compositions containing ondansetron |
May, 2016
(7 years ago) | |
Zofran is owned by Sandoz.
Zofran contains Ondansetron Hydrochloride.
Zofran has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Zofran are:
- US5854270
- US5854270*PED
Zofran was authorised for market use on 24 January, 1997.
Zofran is available in solution;oral dosage forms.
Zofran can be used as relief of nausea and vomiting.
The generics of Zofran are possible to be released after 20 May, 2016.
Drugs and Companies using ONDANSETRON HYDROCHLORIDE ingredient
Market Authorisation Date: 24 January, 1997
Treatment: Relief of nausea and vomiting
Dosage: SOLUTION;ORAL
How can I launch a generic of ZOFRAN before it's drug patent expiration?
More Information on Dosage
ZOFRAN family patents
